Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 7 hits in this display
BDBM298285(US10123984, Example 2A | US10744104, Example 2A | ...)
Neprilysin(Homo sapiens (Human))Theravance Biopharma R&D Ip
US Patent
BDBM298285(US10123984, Example 2A | US10744104, Example 2A | ...)
BDBM298285(US10123984, Example 2A | US10744104, Example 2A | ...)
Ki: <1nMAssay Description:The assays were performed in 384-well white opaque plates at 37? C. using the fluorogenic peptide substrates at a concentration of 10 μM in Assa...More data for this Ligand-Target Pair
BDBM298285(US10123984, Example 2A | US10744104, Example 2A | ...)
Ki: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
Neprilysin(Homo sapiens (Human))Theravance Biopharma R&D Ip
US Patent
BDBM298285(US10123984, Example 2A | US10744104, Example 2A | ...)
Neprilysin(Homo sapiens (Human))Theravance Biopharma R&D Ip
US Patent
BDBM298285(US10123984, Example 2A | US10744104, Example 2A | ...)
Neprilysin(Homo sapiens (Human))Theravance Biopharma R&D Ip
US Patent
BDBM298285(US10123984, Example 2A | US10744104, Example 2A | ...)
Ki: 3.98nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair